Developing retinal biomarkers of neurological disease: an analytical perspective

被引:3
|
作者
MacCormick, Ian J. C. [1 ,2 ,3 ]
Czanner, Gabriela [1 ,4 ]
Faragher, Brian [5 ]
机构
[1] Univ Liverpool, Dept Eye & Vis Sci, Liverpool L69 3BX, Merseyside, England
[2] Malawi Liverpool Wellcome Trust, Clin Res Programme, Blantyre, Malawi
[3] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland
[4] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England
[5] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England
基金
英国惠康基金;
关键词
biomarker; brain; cerebral malaria; proxy marker; retina; surrogate end point; SURROGATE END-POINTS; CEREBRAL MALARIA; CLINICAL-TRIALS; CHILDREN; VALIDATION; BRAIN;
D O I
10.2217/BMM.15.17
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The inaccessibility of the brain poses a problem for neuroscience. Scientists have traditionally responded by developing biomarkers for brain physiology and disease. The retina is an attractive source of biomarkers since it shares many features with the brain. Some even describe the retina as a 'window' to the brain, implying that retinal signs are analogous to brain disease features. However, new analytical methods are needed to show whether or not retinal signs really are equivalent to brain abnormalities, since this requires greater evidence than direct associations between retina and brain. We, therefore propose a new way to think about, and test, how clearly one might see the brain through the retinal window, using cerebral malaria as a case study.
引用
收藏
页码:691 / 701
页数:11
相关论文
共 50 条
  • [31] Atrial Fibrillation in Cerebrovascular Disease: National Neurological Perspective
    Sargento-Freitas, Joao
    Silva, Fernando
    Koehler, Sebastian
    Isidoro, Luis
    Mendonca, Nuno
    Machado, Cristina
    Cordeiro, Gustavo
    Cunha, Luis
    ACTA MEDICA PORTUGUESA, 2013, 26 (02): : 86 - 92
  • [32] Analytical methodologies utilized in the search for chronic disease biomarkers
    Hyotylainen, Tuulia
    BIOANALYSIS, 2010, 2 (05) : 919 - 923
  • [33] Analytical aspects of molecular Alzheimer's disease biomarkers
    Andreasson, Ulf
    Vanmechelen, Eugeen
    Shaw, Leslie M.
    Zetterberg, Henrik
    Vanderstichele, Hugo
    BIOMARKERS IN MEDICINE, 2012, 6 (04) : 377 - 389
  • [34] Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program
    Gwinn, Katrina
    David, Karen K.
    Swanson-Fischer, Christine
    Albin, Roger
    St Hillaire-Clarke, Coryse
    Sieber, Beth-Anne
    Lungu, Codrin
    Bowman, F. DuBois
    Alcalay, Roy N.
    Babcock, Debra
    Dawson, Ted M.
    Dewey, Richard B., Jr.
    Foroud, Tatiana
    German, Dwight
    Huang, Xuemei
    Petyuk, Vlad
    Potashkin, Judith A.
    Saunders-Pullman, Rachel
    Sutherland, Margaret
    Walt, David R.
    West, Andrew B.
    Zhang, Jing
    Chen-Plotkin, Alice
    Scherzer, Clemens R.
    Vaillancourt, David E.
    Rosenthal, Liana S.
    BIOMARKERS IN MEDICINE, 2017, 11 (06) : 451 - 473
  • [35] Developing predictive biomarkers for dementia of Parkinson's disease
    Caviness, John N.
    Aarsland, Dag
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (12) : 1661 - 1663
  • [36] Role of Biomarkers in Developing New Therapies for Vascular Disease
    Vijay Nambi
    Christie M. Ballantyne
    World Journal of Surgery, 2007, 31 : 676 - 681
  • [37] Role of biomarkers in developing new therapies for vascular disease
    Nambi, Vijay
    Ballantyne, Christie M.
    WORLD JOURNAL OF SURGERY, 2007, 31 (04) : 676 - 681
  • [39] A perspective on the challenges and issues in developing biomarkers for human allergic risk assessments
    Mu, Ying
    Godar, Dianne E.
    Merrill, Stephen J.
    BIOMARKERS IN MEDICINE, 2017, 11 (07) : 523 - 526
  • [40] GRANINS AS DISEASE-BIOMARKERS: TRANSLATIONAL POTENTIAL FOR PSYCHIATRIC AND NEUROLOGICAL DISORDERS
    Bartolomucci, A.
    Pasinetti, G. M.
    Salton, S. R. J.
    NEUROSCIENCE, 2010, 170 (01) : 289 - 297